Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amitifadine in Major Depressive Disorder
NCT00659347Phase 2Terminated
- Sponsor
- DOV Pharmaceutical, Inc.
- Start
- Mar 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of amitifadine in major depressive disorder (MDD), sponsored by DOV Pharmaceutical, Inc.. Started Mar 2008; status: terminated.
02
Drugs
amitifadine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00659347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00659347.